Propanc Biopharma's total assets for Q3 2025 were $22.53M, an increase of 28585.20% from the previous quarter. PPCB total liabilities were $4.44M for the fiscal quarter, a 4.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.